Virtual Screening of Dual-Mechanism Proton Pump Inhibitors of Traditional Chinese Medicine

TIAN Chuan,ZHU Ruixin,WU Ping,WANG Te,CAO Zhiwei,KANG Tingguo
2013-01-01
Abstract:Proton pump inhibitors could effectively treat acid-related diseases.Drugs marketed and in clinical trials mainly include irreversible and reversible types.One leading compound with both mechanisms would potentially become more potent proton pump inhibitor.With advanced molecular simulation technique,pharmacophore models of both mechanisms were built in our study.Positive accuracy(over 70%)and negative accuracy(over 90%)indicated that models showed high prediction ability.Since 70% of current drugs marketed derived from traditional Chinese medicine,we performed virtual screening of dual-mechanism proton pump inhibitors through traditional Chinese medicine database.Diverse subset was utilized to select 1000 compounds as candidates.Pharmacophore models were further employed to obtain 26 compounds taken as dual-mechanism leading compound of both irreversible and reversible mechanisms.Among them,compound 14 derived from Murraya paniculata which is used to treat gastralgia.This study provides an understanding of mechanism of Sanjiu Weitai Capsules at the molecular level.Our method could be applied to other virtual screening studies of traditional Chinese medicine as well.
What problem does this paper attempt to address?